ArticleDigestive diseases and sciences2023

Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn's Disease Initiating Vedolizumab Versus Ustekinumab.

Michael D Kappelman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.